HOTH — Stock activity · TradeandTellHOTH
HOTH
$1.36+$0.65 (+92.01%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$0.49 – $2.12
54% from low
Held by traders on TradeandTell
No one on the platform currently holds HOTH.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HOTH as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|
| 2022-10-26 | 1-for-25reverse |
Recent trades on TradeandTell
No one on the platform has traded HOTH yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $0 | -100.0% | $-0.59 | $-0.59–$-0.59 | — | 1 |
| 2027 | $0 | — | $-0.70 | $-0.70–$-0.70 | — | 1 |
| 2028 | $0 | — | $-1.19 | $-1.19–$-1.19 | — | 1 |
| 2029 | $131M | — | $1.15 | $1.15–$1.15 | 1.2× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2026-05-15 | $-0.14 | $-0.17 | -23.4% |
| 2026-03-27 | $-0.10 | $-0.16 | -55.2% |
| 2025-11-12 | $-0.30 | $-0.30 | +0.0% |
| 2025-08-12 | $-0.27 | $-0.17 | +37.0% |
| 2025-05-12 | $-0.34 | $-0.27 | +20.6% |
| 2025-03-28 | $-0.39 | $-0.32 | +17.9% |
| 2024-11-12 | $-0.30 | $-0.31 | -3.3% |
| 2024-08-09 | $-0.39 |
DCF fair valuemodel estimate
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| HOTHHoth Therapeutics, Inc. | $0.80 | -2.22% | $11M | — |
| ASBPAspire Biopharma Holdings, Inc. | $7.30 | +2.67% | $842216 | — |
| BCTXBriaCell Therapeutics Corp. | $3.38 | -1.74% | $29M | — |
| CRISCuris, Inc. | $1.92 | +2.78% | $4M | — |
| DAREDare Bioscience, Inc. | $1.43 | +4.38% |
| ENTOEntero Therapeutics, Inc. | $2.85 | -5.00% | $14M | — |
| FBLGFibroBiologics, Inc. Common Stock | $1.09 | -5.22% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry